US Edition
Trump announces reforms to accelerate access to psychedelic drug treatments
The order directs the Food and Drug Administration to speed reviews and fund research as officials cite promising early results and veteran demand.
- On Saturday, April 18, 2026, President Donald Trump signed an executive order directing federal agencies to expedite research on psychedelic drugs, including ibogaine, and committed $50 million to federal research.
- Health Secretary Robert F. Kennedy Jr. and podcaster Joe Rogan joined Trump at the Oval Office, highlighting veteran mental health crises; Kennedy noted thousands of veterans travel to Mexico for treatments due to domestic restrictions.
- Trump cited a 2024 Stanford University study showing 30 special operations veterans experienced an 80% to 90% reduction in depression and anxiety symptoms within one month, though critics warn ibogaine remains classified as Schedule I with known cardiotoxicity risks.
- FDA Commissioner Marty Makary announced the agency will issue national priority vouchers next week to accelerate reviews, targeting approvals within weeks, while opening a Right-to-Try pathway for terminally ill patients.
- While ibogaine remains Schedule I, the order signals a shift from underground use to federal acknowledgment, potentially encouraging states to fund university research programs and reshaping access for veterans long-term.
160 Articles
160 Articles
With Executive Order, Trump Accelerates Psychedelic Research, Joking: ‘Can I Have Some?’
‘In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans,’ the president says.
Trump Signs Order To Fast-Track Psychedelic Treatments For Veterans; Rogan Joins In Oval Office
President Trump cut through decades of federal red tape on Saturday by signing an executive order in the Oval Office that accelerates research and access to promising psychedelic therapies for America’s veterans battling PTSD, traumatic brain injuries, depression, and addiction. The move prioritizes results for those who served, putting veteran lives ahead of outdated bureaucratic barriers that have lingered since the 1970 Controlled Substances …
Channel News Asia
GV WireTrump signs order to accelerate access to psychedelic drug treatments
Health Secretary Robert F. Kennedy Jr. has championed the idea of using drugs such as ibogaine as an alternative treatment for mental health conditions such as depression.
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
